The effect of topical hydrocortisone in the treatment of anal fisher

Evaluation of the efficacy of topical hydrocortisone in the treatment of rectal fissure in patients undergoing pharmacological treatment referred to Fatemi Hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191224045888N1

Enrollment

200

Registered

2020-05-29

Start date

2018-09-23

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic anal fissure. Chronic anal fissure

Interventions

Intervention 1: Intervention Group 1:This group includes 100 patients with chronic Fisher's disease. For 3 months, these patients are treated with Diltiazem 2.% made by sobhan company pea gel about ha

Eligibility

Sex/Gender

All

Age

15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Chronic Anal Fisher

Exclusion criteria

Exclusion criteria: Any drug addiction Peri anal surgery history Hemorrhoids at the same time Acute Fisher Patients with Crohn's disease Patients with ulcerative colitis Patients with hypothyroidism

Design outcomes

Primary

Measure	Time frame
Pain scale. Timepoint: On first visit, 2 weeks later, 6 weeks later, 3 months later. Method of measurement: NRS (numerical rating scale) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Notash

Ardabil University of Medical Sciences

meisamfooladi@gmail.com+98 45 3323 0739

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026